检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
作 者:郭晓菲 GUO Xiaofei(Lyushunkou District People's Hospital of Dalian,Dalian 116041,China)
机构地区:[1]辽宁省大连市旅顺口区人民医院,辽宁大连116041
出 处:《中国医药指南》2021年第5期96-97,共2页Guide of China Medicine
摘 要:目的探讨米力农治疗顽固性心力衰竭的效果。方法选择2017年2月至2019年3月我院收治的顽固性心力衰竭患者38例作为观察组,另选同时期来我院治疗的顽固性心力衰竭患者38例作为对照组,对照组采用常规治疗方案进行治疗,观察组在此基础上应用米力农治疗,比较两组治疗效果。结果观察组治疗有效率为94.74%,高于对照组的73.68%,P<0.05;观察组不良反应发生率为2.63%,低于对照组的7.89%,P<0.05;观察组心排血量和左室射血分数明显优于对照组,P<0.05。结论米力农治疗顽固性心力衰竭患者可有效帮助患者提升治疗有效率,降低不良反应发生率,同时帮助患者改善临床症状。Objective To analyze the effect of milrinone on the treatment of refractory heart failure. Methods Thirty-eight patients with tefractory heart failure admitted to our hospital from February 2017 to March 2019 were selected as the observation group, and 38 patients with refractory heart failure who came to our hospital during the same period were selected as the control group, and the control group was treated with conventional treatment plan, and the observation group was treated with milrinone on control group, and the treatment effects of the two groups were compared. Results The effective rate of treatment in the observation group was 94.74%, which was higher than in the control group(73.68%), P<0.05;the incidence of adverse reactions in the observation group was 2.63%, which was lower than in the control group(7.89%), P<0.05;The cardiac output and left ventricular ejection fraction of the observation group were significantly better than those of the control group, P<0.05. Conclusion Milrinone treatment of patients with refractory heart failure can effectively help patients improve the treatment efficiency, reduce the incidence of adverse reactions, and help patients improve their clinical symptoms.
分 类 号:R541.6[医药卫生—心血管疾病]
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:216.73.216.3